Cytomegalovirus genetic diversity following primary infection.

Publication Type
Journal Article
Year of Publication
2019
Authors
Ross, Shannon; Pati, Pravasini; Jensen, Travis L; Goll, Johannes B; Gelber, Casey E; Singh, Amy; McNeal, Monica; Boppana, Suresh B; Bernstein, David I
Secondary
J Infect Dis
Date Published
2019 Oct 08
Keywords
cytomegalovirus; diversity; primary infection; strains
Abstract

BACKGROUND: Infection with multiple cytomegalovirus (CMV) strains (mixed infection) was reported in a variety of hosts. Since, the virus genetic diversity in primary CMV infection and the changes over time remain incompletely undefined, we examined CMV diversity and changes in diversity over time in healthy adolescent females who participated in a phase II CMV gB/MF59 vaccine trial.

METHODS: CMV genetic diversity was determined by genotyping of five genes; gB (UL55), gH (UL75), gN (UL73), US28, UL144, in urine, saliva, and plasma samples from 15 study subjects.

RESULTS: At the time of primary infection, 5/12 (42%) urine samples had multiple virus strains and 50% of vaccine recipients were infected with gB1 genotype (vaccine strain). Mixed infection was documented in all 15 subjects within 3 months after primary infection and the majority had different CMV genotypes in different compartments. Changes in genotypes over time were observed in all subjects.

CONCLUSION: Infection with multiple CMV genotypes was common during primary infection and further diversification occurred over time. Infection with gB1 genotype in vaccine recipients suggests a lack of strain specific protection from the vaccine. As only 5 polymorphic genes were assessed, this study likely underestimated the true genetic diversity in primary CMV infection.